Why Charlotte’s Web (TSX:CWEB) Stock Is Crashing Today

Charlotte’s Web (TSX:CWEB) could be an attractive buy on the dip.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Today, shares of Charlotte’s Web (TSX:CWEB) were down more than 15% by midday. That’s because earlier in the day, the company announced that it would be issuing shares that would help it raise $67.5 million. The offering would be for 10 million shares at a price of $6.75. There is an option for an additional 1.5 million shares that, if exercised fully, could lead to Charlotte’s Web raising more than $77.6 million in total.

Not only does the deal mean more dilution for shareholders, but it’s at a lower price than where the stock closed at on Monday — $7.32. And so it’s no surprise that there’s been a sell-off happening as a result. Any time there’s a hint that there may be downward pressure on a stock price, many investors may look to sell their shares to minimize potential losses.

Should long-term investors be concerned?

Equity issues are nothing new for the cannabis industry, as cash is always at a premium in the industry. In the press release, Charlotte’s Web said that the “net proceeds from the offering are expected to be used primarily to fund the company’s business development and for general working capital purposes.”

It’s those last few words that may irk investors, as any time you see a vague reason such as “general working capital” for the reason of an equity issue, it suggests that the company may not have sufficient cash on hand. There could be many bankruptcies in the cannabis industry due to COVID-19, and so it’s definitely going to raise some eyebrows when a cannabis company is raising money to fund its day-to-day working capital needs.

The Colorado-based cannabis company released its most recent quarterly results on May 14. It reported that as of March 31 it had US$53 million of cash on hand. That’s down from US$68.6 million on December 31, 2019. During the first three months of the year, Charlotte’s Web burned through US$14.9 million just from its day-to-day operating activities. And while that would suggest that its cash on hand may be sufficient to last multiple quarters, the COVID-19 pandemic may be stretching its operations thin, especially if sales haven’t been strong.

Is Charlotte’s Web a buy on the dip?

With the stock falling on Tuesday, it could be an opportune time for investors to consider buying it. It was about a month ago that the stock was trading below $6.20. There’s a possibility that it could continue to go lower, but maybe not all that much. Outside of the March market crash, where it fell to just above $4 a share, the stock has seen fairly stable support around $5.70, and in May it even hit a high of more than $10.

The closer the stock gets to $6 the better of a buy it becomes. Although Charlotte’s Web has failed to post a profit in its last three quarters, that hasn’t normally been the case for the company. And if it can get back to breakeven, it could again become one of the safer cannabis investments to hold. And now, with an influx of cash coming the company’s way, liquidity is something that investors may not have to worry about for a while.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Charlottes Web Holdings.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »